Charles Schwab Investment Management Inc Bio Rad Laboratories, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 184,315 shares of BIO stock, worth $61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
184,315
Previous 230,656
20.09%
Holding current value
$61 Million
Previous $63 Million
2.1%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$513 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$431 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$359 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$236 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.15B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...